BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8903094)

  • 1. The diagnostic and prognostic significance of ANCA.
    Lesavre P
    Ren Fail; 1996 Sep; 18(5):803-12. PubMed ID: 8903094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.
    Schultz DR; Tozman EC
    Semin Arthritis Rheum; 1995 Dec; 25(3):143-59. PubMed ID: 8650585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review.
    Jennette JC; Falk RJ
    Am J Kidney Dis; 1990 Jun; 15(6):517-29. PubMed ID: 1973331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.
    Kallenberg CG; Mulder AH; Tervaert JW
    Am J Med; 1992 Dec; 93(6):675-82. PubMed ID: 1466365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies (ANCA).
    Radice A; Sinico RA
    Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antineutrophil cytoplasmic antibodies].
    Sebastiani GD
    Reumatismo; 2009; 61(1):69-76. PubMed ID: 19370191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
    Wiik A; Brimnes J; Heegaard NH
    Isr Med Assoc J; 1999 Sep; 1(1):4-7. PubMed ID: 11370121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antineutrophil cytoplasm antibodies (ANCA): description and immunopathological role].
    Noël LH
    Ann Med Interne (Paris); 2000 May; 151(3):178-83. PubMed ID: 10896969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen specificities and clinical distribution of ANCA in kidney diseases.
    Lesavre P; Noël LH; Chauveau D; Geffriaud C; Grünfeld JP
    Klin Wochenschr; 1991 Sep; 69(13):552-7. PubMed ID: 1721665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
    Gross WL
    Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases.
    Schnabel A; Hauschild S; Gross WL
    Int Arch Allergy Immunol; 1996 Mar; 109(3):201-6. PubMed ID: 8620087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
    Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.